Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
84,771,135
-
Share change
-
-2,714,296
-
Total reported value
-
$3,855,815,900
-
Put/Call ratio
-
16%
-
Price per share
-
$45.45
-
Number of holders
-
223
-
Value change
-
-$118,002,301
-
Number of buys
-
104
-
Number of sells
-
113
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2016
As of 30 Jun 2016 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 84,771,135 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BB BIOTECH AG, PERCEPTIVE ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, and ORBIMED ADVISORS LLC.
This table shows 223 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.